Review Papers Faster

 Quick Explanation Copied

 Long Explanation

Core evidence. Site-directed mutagenesis of hAPN in non-permissive murine CMT93 cells showed that six substitutions (p6-hAPN) introducing an N291 glycosylation sequon abolished HCoV-229E receptor activity, while single revertants (E291KT or N291KQ) removing the sequon restored infection, with radiolabeled-virus binding dropping from 100% (wt) to 3.1% (p6-hAPN) and 17.4% (N291KT) Quantitative binding and infection data from Wentworth and Holmes. Comparable surface expression (FACS-sorted) and preserved enzymatic/antibody-epitope profiles argue the effect reflects glycan-mediated steric hindrance of virus binding, not misfolding or trafficking defects.

Counter-evidence and boundary conditions the authors addressed. Removing a second, non-conserved sequon (N818E) did not confer TGEV or FECoV receptor activity on hAPN, and the authors themselves note that removing the analogous N286 sequon from pAPN also fails to confer HCoV-229E susceptibility N818 mutagenesis result excluding glycosylation as sole determinant. The paper therefore qualifies its own headline: glycosylation modulates, but does not alone determine, species specificity.

Critical assessment. Reported observations are internally consistent and multiply triangulated (IFA, immunoblot, virus titers, direct binding), a strength. However, all work is in overexpressing cell lines; glycosylation occupancy at N291 was inferred from phenotypes (partial IFA positivity for N291KT suggests incomplete occupancy) rather than directly mapped glycans, and no structural evidence localizes the true spike-binding site Incomplete glycosylation caveat in N291KT cells. What would change the conclusion: direct glycoproteomic proof that N291 is glycosylated in vivo on respiratory epithelium, or a structurally resolved spike–APN complex showing direct contact at 288–295.

Context. CD13 is a multifunctional moonlighting enzyme with diverse tissue-specific expression CD13 moonlighting functions review, and receptor surface density itself is environmentally tunable—e.g., lowered extracellular pH increases HL60 CD13 surface content ~60–70% without mRNA change pH-dependent CD13 surface regulation study—both relevant caveats when extrapolating this in vitro host-range work to tissue tropism in vivo.

Test N291 Glycan Hypothesis In Vivo Rebuild Binding Graphs Run AI Scientist Analysis Make Poster

Author Review: David E. Wentworth Author Review: Kathryn V. Holmes

 BGPT Paper Review

Study Novelty

First demonstration that receptor N-linked glycosylation modulates serogroup 1 coronavirus species specificity; glycan effects on viral attachment proteins were known, but receptor-side glycan control of host range was novel in 2001.

Scientific Quality

Multiple orthogonal assays (binding, IFA, immunoblot, titer), FACS-matched expression controls, enzymatic/epitope checks, and honest qualification (N818 null result) make this strong mechanistic work; deduct small points for inference of glycosylation occupancy without direct glycan mapping and no structural localization.

Study Generality

Principles extend to other virus-receptor systems (CAT-1/MuLV parallel), but conclusions are bounded to serogroup 1 coronaviruses and hAPN/pAPN/fAPN comparisons.

Study Usefulness

Directly informs host-range determinants, tropism, and design of receptor-mutagenesis experiments; contributed conceptual groundwork later used for coronavirus receptor studies.

Study Reproducibility

Full primer sequences, cloning strategy, cell lines, FACS sort criteria, and assay parameters reported; constructs described precisely.

Explanatory Depth

Mechanistic causal chain (glycan addition → binding blockade → infection loss) is well supported at the cellular level, though the atomic-scale binding site and glycan structure remain inferred.